Kisspeptin-10 inhibits angiogenesis in human placental vessels ex vivo and endothelial cells in vitro

Endocrinology

Volumn 151, Issue 12, 2010, Pages 5927-5934

  Ramaesh, Thayalini ^a   Logie, James J ^a   Roseweir, Antonia K ^b   Millar, Robert P ^b,c   Walker, Brian R ^a   Hadoke, Patrick W F ^a   Reynolds, Rebecca M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MRC Reproductive Biology Unit   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR 54; KISSPEPTIN 10;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; PLACENTA FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FEMALE; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PREGNANCY; TUMOR SUPPRESSOR PROTEINS;

EID: 78649827304     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0565     Document Type: Article

References (38)

1. Demir R, Seval Y, Huppertz B 2007 Vasculogenesis and angiogenesis in the early human placenta. Acta Histochem 109:257-265
2. Guimarães Filho HA, da Costa LL, Araújo Júnior E, Nardozza LM, Nowak PM, Moron AF, Mattar R, Pires CR 2008 Placenta: angiogenesis and vascular assessment through three-dimensional power Doppler ultrasonography. Arch Gynecol Obstet 277:195-200
3. Redman CW, Sargent IL 2009 Placental stress and pre-eclampsia: a revised view. Placenta 30(Suppl A):S38-S42
4. Hiden U, Bilban M, Knöfler M, Desoye G 2007 Kisspeptins and the placenta: regulation of trophoblast invasion. Rev Endocr Metab Disord 8:31-39
5. Reynolds RM, Logie JJ, Roseweir AK, McKnight AJ, Millar RP 2009 A role for kisspeptins in pregnancy: facts and speculations. Reproduction 138:1-7
6. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E 2003 Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 100:10972-10976
7. Seminara SB, Messager S, Chatzidaki EE, Thresher RR, Acierno Jr JS, Shagoury JK, Bo-Abbas Y, Kuohung W, Schwinof KM, Hendrick AG, Zahn D, Dixon J, Kaiser UB, Slaugenhaupt SA, Gusella JF, O'Rahilly S, Carlton MB, Crowley Jr WF , Aparicio SA, Colledge WH 2003 The GPR54 gene as a regulator of puberty. N Engl J Med 349:1614-1627
8. Semple RK, Achermann JC, Ellery J, Farooqi IS, Karet FE, Stanhope RG, O'rahilly S, Aparicio SA 2005 Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 90:1849-1855
9. Lanfranco F, Gromoll J, von Eckardstein S, Herding EM, Nieschlag E, Simoni M 2005 Role of sequence variations of the GnRH receptor and G protein-coupled receptor 54 gene in male idiopathic hypogonadotropic hypogonadism. Eur J Endocrinol 153:845-852
10. Dhillo WS, Chaudhri OB, Patterson M, Thompson EL, Murphy KG, Badman MK, McGowan BM, Amber V, Patel S, Ghatei MA, Bloom SR 2005 Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab 90:6609-6615
11. Tena-Sempere M 2006 KiSS-1 and reproduction: focus on its role in the metabolic regulation of fertility. Neuroendocrinology 83:275-281
12. Roseweir AK, Millar RP 2009 The role of kisspeptin in the control of gonadotrophin secretion. Hum Reprod Update 15:203-212
13. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR 1996 KiSS-1, a novel human malignant melanoma metastasis- suppressor gene. J Natl Cancer Inst 88:1731-1737
14. Lee JH, Welch DR 1997 Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 57:2384-2387
15. Jiang Y, Berk M, Singh LS, Tan H, Yin L, Powell CT, Xu Y 2005 KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase Cα. Clin Exp Metastasis 22:369-376
16. Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brézillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C, Schiffmann SN, Vassart G, Parmentier M 2001 The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem 276:34631-34636
17. Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, Ishibashi Y, Watanabe T, Asada M, Yamada T, Suenaga M, Kitada C, Usuki S, Kurokawa T, Onda H, Nishimura O, Fujino M 2001 Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411:613-617
18. Muir AI, Chamberlain L, Elshourbagy NA, Michalovich D, Moore DJ, Calamari A, Szekeres PG, Sarau HM, Chambers JK, Murdock P, Steplewski K, Shabon U, Miller JE, Middleton SE, Darker JG, Larminie CG, Wilson S, Bergsma DJ, Emson P, Faull R, Philpott KL, Harrison DC 2001 AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem 276:28969-28975
19. Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S, Fujino M 2003 Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab 88:914-919
20. Dhillo WS, Savage P, Murphy KG, Chaudhri OB, Patterson M, Nijher GM, Foggo VM, Dancey GS, Mitchell H, Seckl MJ, Ghatei MA, Bloom SR 2006 Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment. Am J Physiol Endocrinol Metab 291:E878-E884
21. Bilban M, Ghaffari-Tabrizi N, Hintermann E, Bauer S, Molzer S, Zoratti C, Malli R, Sharabi A, Hiden U, Graier W, Knöfler M, Andreae F, Wagner O, Quaranta V, Desoye G 2004 Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. J Cell Sci 117:1319-1328
22. Janneau JL, Maldonado-Estrada J, Tachdjian G, Miran I, Motté N, Saulnier P, Sabourin JC, Coté JF, Simon B, Frydman R, Chaouat G, Bellet D 2002 Transcriptional expression of genes involved in cell invasion and migration by normal and tumoral trophoblast cells. J Clin Endocrinol Metab 87:5336-5339
23. Zygmunt M, Herr F, Munstedt K, Lang U, Liang OD 2003 Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol 110(Suppl 1):S10-S18
24. Mead EJ, Maguire JJ, Kuc RE, Davenport AP 2007 Kisspeptins are novel potent vasoconstrictors in humans, with a discrete localization of their receptor, G protein-coupled receptor 54, to atherosclerosisprone vessels. Endocrinology 148:140-147
25. Murat A, Migliavacca E, Hussain SF, Heimberger AB, Desbaillets I, Hamou MF, Rüegg C, Stupp R, Delorenzi M, Hegi ME 2009 Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia. PloS One 4:e5947
26. Cho SG, Yi Z, Pang X, Yi T, Wang Y, Luo J, Wu Z, Li D, Liu M 2009 Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation. Cancer Res 69:7062-7070
27. Bocci G, Fasciani A, Danesi R, Viacava P, Genazzani AR, Del Tacca M 2001 In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vessels. Mol Hum Reprod 7:771-777
28. Zhu WH, Iurlaro M, MacIntyre A, Fogel E, Nicosia RF 2003 The mouse aorta model: influence of genetic background and aging on bFGF- and VEGF-induced angiogenic sprouting. Angiogenesis 6:193-199
29. Li Q, Olsen BR 2004 Increased angiogenic response in aortic explants of collagen XVIII/endostatin-null mice. Am J Pathol 165:415-424
30. Small GR, Hadoke PW, Sharif I, Dover AR, Armour D, Kenyon CJ, Gray GA, Walker BR 2005 Preventing local regeneration of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1 enhances angiogenesis. Proc Natl Acad Sci USA 102:12165-12170
31. Genbacev O, Schubach SA, Miller RK 1992 Villous culture of first trimester human placenta - model to study extravillous trophoblast (EVT) differentiation. Placenta 13:439-461
32. Miller RK, Genbacev O, Turner MA, Aplin JD, Caniggia I, Huppertz B 2005 Human placental explants in culture: approaches and assessments. Placenta 26:439-448
33. Hori A, Honda S, Asada M, Ohtaki T, Oda K, Watanabe T, Shintani Y, Yamada T, Suenaga M, Kitada C, Onda H, Kurokawa T, Nishimura O, Fujino M 2001 Metastin suppresses the motility and growth of CHO cells transfected with its receptor. Biochem Bioph Res Co 286:958-963
34. Regnault TR, Galan HL, Parker TA, Anthony RV 2002 Placental development in normal and compromised pregnancies - a review. Placenta 23(Suppl A):S119-S129
35. Sibley CP, Turner MA, Cetin I, Ayuk P, Boyd CA, D'Souza SW, Glazier JD, Greenwood SL, Jansson T, Powell T 2005 Placental phenotypes of intrauterine growth. Pediatr Res 58:827-832
36. Qiao C, Wang CH, Shang T, Lin QD 2005 Clinical significance of KiSS-1 and matrix metalloproteinase-9 expression in trophoblasts of women with preeclampsia and their relation to perinatal outcome of neonates. Zhonghua Fu Chan Ke Za Zhi 40:585-590
37. Smets EM, Deurloo KL, Go AT, van Vugt JM, Blankenstein MA, Oudejans CB 2008 Decreased plasma levels of metastin in early pregnancy are associated with small for gestational age neonates. Prenat Diagn 28:299-303
38. Armstrong RA, Reynolds RM, Leask R, Shearing CH, Calder AA, Riley SC 2009 Decreased serum levels of kisspeptin in early pregnancy are associated with intra-uterine growth restriction and preeclampsia. Prenat Diagn 29:982-985